Log in to MyACC
AHA 2016 | Highlights - Part 2
Nov 16, 2016 | Video Interview
Full ACC.org Coverage of AHA Scientific Sessions 2016
Day 4
ATHENA HF: Aldosterone-Targeted Neurohormonal Combined With Natriuresis Therapy in HF
Nov 16, 2016 | Clinical Trial | Anthony A. Bavry, M.D., M.P.H., FACC
ATHENA HF: High-Dose Spironolactone in Acute HF
Nov 16, 2016 | ACC News Story
Video Interview: ATHENA-HF
Nov 16, 2016 | Video Interview
MOMENTUM 3: HeartMate 3 vs. HeartMate II in Advanced HF
Nov 16, 2016 | ACC News Story
Video Interview: Momentum
Nov 16, 2016 | Video Interview
Studies Explore Use of Iron Supplements in Treating HF Patients
Nov 16, 2016 | ACC News Story
MultiSENSE: A Multi-Sensor Algorithm Predicts HF Events in Patients With Implanted Devices
Nov 16, 2016 | ACC News Story
Day 3
GAUSS-3: Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects 3
Nov 15, 2016 | Clinical Trial | Dharam J. Kumbhani, MD, SM, FACC
GAUSS-3: Pathogenesis of Statin-Associated Muscle Symptoms
Nov 15, 2016 | ACC News Story
Effect of CETP Loss-of-Function Variant on Risk of CVD in Chinese Adults
Nov 15, 2016 | News Story
Studies Offer Insight on New Lipid Therapies
Nov 15, 2016 | ACC News Story
CAC Improves Risk Prediction Among Low-Risk Women
Nov 15, 2016 | Journal Scan | Elizabeth A. Jackson, MD, FACC
GLAGOV: Does Evolucumab Affect the Progression of CHD?
Nov 15, 2016 | ACC News Story
Heart Failure Readmission Penalties, Care Quality, Outcomes
Nov 15, 2016 | Journal Scan | Debabrata Mukherjee, MD, FACC
Does A Focus on 30-Day HF Readmission Rates Improve Outcomes, Quality of Care?
Nov 15, 2016 | ACC News Story
Cardiac Stress Test Trends Among US Patients <65 Years
Nov 15, 2016 | Journal Scan | David S. Bach, MD, FACC
ORION 1: Inhibition of PCSK9 Synthesis Via RNA Interference
Nov 15, 2016 | ACC News Story
GLAGOV: Does Evolucumab Affect the Progression of CHD?
Nov 15, 2016 | ACC News Story
AHA 2016 | Highlights - Part 1
Nov 15, 2016 | Video Interview
Day 2
The NHLBI TIME Trial: Role of Microvascular Obstruction in 2-Year Clinical and MRI Follow-Up
Nov 14, 2016 | Clinical Trial | Anthony A. Bavry, M.D., M.P.H., FACC
MOBILE: Administration of Autologous Bone Marrow Cells For Limb Salvage in CLI
Nov 14, 2016 | Clinical Trial | Anthony A. Bavry, M.D., M.P.H., FACC
POSEIDON-DCM: Allogenic vs. Autologous Stem Cells in Non-Ischemic Dilated Cardiomyopathy
Nov 14, 2016 | ACC News Story
Excess Cardiovascular Risk in Women With Low Flow Reserve
Nov 14, 2016 | Journal Scan | Elizabeth A. Jackson, MD, FACC
Risk of Hyperkalemia With Mineralocorticoid Receptor Antagonists
Nov 14, 2016 | Journal Scan | Debabrata Mukherjee, MD, FACC
GARY: TAVR vs. SAVR in Intermediate Surgical Risk Severe AS
Nov 14, 2016 | ACC News Story
FUTURE: FFR-Guided Revascularization vs. Angioplasty in CAD Patients
Nov 14, 2016 | ACC News Story
ART: Single vs. Bilateral Grafts in CAD Patients Undergoing CABG
Nov 14, 2016 | ACC News Story
Video Interview: PIONEER AF-PCI
Nov 14, 2016 | Video Interview
PIONEER AF-PCI: Rivaroxaban Plus P2Y12 Inhibitor or DAPT in Post-PCI AFib Patients
Nov 14, 2016 | ACC News Story
Incomplete Revascularization May Lead to Higher Rates of MI Following Non-Cardiac Surgery
Nov 14, 2016 | ACC News Story
BiomarCaRE: Lifetime Risk of CVD in Europe
Nov 14, 2016 | ACC News Story
GHP-CHANGE: Peer-Group Intervention in Grenada
Nov 14, 2016 | ACC News Story
HCPIA (Argentina): Comprehensive Approach For HTN Control in Low-Income Patients in Argentina
Nov 14, 2016 | ACC News Story
RESPONSE 2: Comprehensive Lifestyle Intervention in CAD
Nov 14, 2016 | ACC News Story
GHP-CHANGE: Community Health Action to Encourage Healthy Behaviors
Nov 14, 2016 | Clinical Trial | Anthony A. Bavry, M.D., M.P.H., FACC
Day 1
Examining Use of Ticagrelor in Peripheral Arterial Disease - EUCLID
Nov 13, 2016 | Clinical Trial | Anthony A. Bavry, M.D., M.P.H., FACC
EUCLID: Ticagrelor vs. Clopidogrel in Symptomatic PAD Patients
Nov 13, 2016 | ACC News Story
Video Interview: EUCLID
Nov 13, 2016 | Video Interview
Video Interview: PRECISION
Nov 13, 2016 | Video Interview
PRECISION: Is Celecoxib Non-Inferior to Ibuprofen or Naproxen?
Nov 13, 2016 | ACC News Story
Heart Outcomes Prevention Evaluation – 3 - HOPE-3
Nov 13, 2016 | Clinical Trial | Dharam J. Kumbhani, MD, SM, FACC
HOPE-3: Effect of BP Lowering and Statin Use on Cognitive Function
Nov 13, 2016 | ACC News Story
Video Interview: HOPE 3
Nov 13, 2016 | Video Interview
Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure - TRUE-AHF
Nov 13, 2016 | Clinical Trial | Dharam J. Kumbhani, MD, SM, FACC
Genetic Risk, Lifestyle, and Coronary Disease
Nov 13, 2016 | Journal Scan | Melvyn Rubenfire, MD, FACC
Long-Term Benefit in HF Patients Elusive for Novel Vasodilator
Nov 13, 2016 | MedPage Today
Study Finds Celebrex Safe for Heart
Nov 13, 2016 | MedPage Today
No Cognitive Benefit from Heart Drugs in HOPE-3
Nov 13, 2016 | MedPage Today
More Potent Antiplatelet Agent Not Better for PAD
Nov 13, 2016 | MedPage Today
Healthy Lifestyle Eases Heart Impact of High Genetic Risk
Nov 13, 2016 | MedPage Today
Healthy Lifestyle Significantly Reduces CV Risk Regardless of Genetic Risk
Nov 13, 2016 | ACC News Story
Association Between Secondhand Tobacco Smoke Exposure and Atherosclerosis
Nov 13, 2016 | ACC News Story
CardioBrief: USPSTF Finalizes Statin Primary Prevention Guide, Debate Ensues
Nov 13, 2016 | MedPage Today
New PAD Guideline Emphasizes Medical Therapy, Exercise
Nov 13, 2016 | ACC News Story
AHA/ACC Guideline on the Management of Lower Extremity Peripheral Artery Disease
Nov 13, 2016 | 10 Points to Remember |Geoffrey D. Barnes, MD, FACC
Pre-Conference
Bystander CPR and Survival After Pediatric Cardiac Arrest
Nov 12, 2016 | Journal Scan | Thomas C. Crawford, MD, FACC
Genetic Etiology in Cases of Life-Threatening Arrhythmia
Nov 12, 2016 | ACC News Story
NSAIDs Head-to-Head; Revisiting FFR; Antiplatelets in PAD
Nov 10, 2016 | MedPage Today
